发明名称 |
TUMOR CYTOTOXICITY INDUCED BY MODULATORS OF THE CXCR4 RECEPTOR |
摘要 |
The present invention provides a means of selectively killing epithelial cel l carcinomas by administering a CXCR4-specific sequence of the Gp120 protein o r Nef proteins or the proteins themselves (the modulators) such as that found in strains HIV-1, HIV-2, SIV, or FIV CXCR4-specific Gp 120 sequences or Nef proteins or sequences may be delivered to the mucosa or systemically. The mucosal means of application include oral, intranasal, ocular, intravaginal, rectal, and/or intraurethral administration in liquid or particulate form.</ SDOAB>
|
申请公布号 |
CA2525873(A1) |
申请公布日期 |
2004.11.04 |
申请号 |
CA20032525873 |
申请日期 |
2003.03.20 |
申请人 |
MOREHOUSE SCHOOL OF MEDICINE |
发明人 |
LILLARD, JAMES M.;BOND, VINCENT CRAIG;HUANG, JING BO;POWELL, MICHAEL;BUMPERS, HARVEY |
分类号 |
A61K38/08;A61K;A61K9/00;A61K35/76;A61K38/16;A61P35/00;C07K14/155;C07K14/16 |
主分类号 |
A61K38/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|